We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
Dear colleague letter from Barry Cockcroft, Chief Dental Officer, dated 24 March 2011. Download :National Institute for Health and Clinical…
Information on how the ACBS factors in the issue of pricing, when reviewing product applications.
Extra information for the Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE) Integrated Scientific Advice (ISA) service.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
How to move medicines safely by air, following good distribution practice (GDP).
A pathway summarising the processes pharmaceutical companies should follow when preparing to launch new products in the UK.
The different types of tests and testing kits for COVID-19, and the specifications for manufacturers.
If pharmacies wish to ‘pack down’ larger packs of a medicinal product, they need to follow these instructions
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
Guidance on the submission and content of notifications for Northern Ireland
Guidance on labelling requirements pertinent to the type of medicinal product and its supply status, as defined in UK legislation.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
The call for applications for phase 2 of the AI Airlock is now closed.
Expansion of extra-jurisdictional inspection outcomes.
Due diligence for suppliers of e-cigarettes and e-liquids.
UK government interpretation of the requirements for labelling e-liquids for Northern Ireland.
Interventions that can be made by pharmacy teams, to improve quality of life for older people.
Sets out the payment due from members of the voluntary scheme for branded medicines pricing and access in 2021.
A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).